Umban, Venerando S.
HRN: 26-27-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/05/2026
01/11/2026
IV
2.25
Q8
NON HEALING WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes